
Boehringer Ingelheim swaps lab coats for AI algorithms in search for new drugs
Boehringer Ingelheim is the latest pharma company to turn to AI in the hunt for new treatments and therapies. The German company announced earlier this week that it is working with IBM to use Big Blue's foundation model tech "to discover novel …